The global market for diabetic foods is expected to experience high growth over the forecast horizon. With increasing awareness of the health problems caused by diabetes and an increasing preference for high-quality, healthy, and nutritious foods in India, the diabetic food market is expected to grow steadily in India. Due to the increasing demand, fueled by the growing awareness of diabetes, the market for diabetes products in Asia-Pacific will also continue to develop over the forecast period.
The report provides a detailed analysis of the leading players in the global diabetic food market and provides important trends and opportunities in this market.
The high price of these products is likely to slow down the growth of the diabetic food market worldwide. The global market for diabetic foods is segmented by product type, product type, distribution channel, and region. Diabetic food markets are divided into cereals, carbohydrates, proteins, fats, sugars, proteins, vitamins, minerals, supplements, and other products based on product types.
Diabetes mellitus, commonly known as diabetes, is a metabolic disorder that impairs the body’s ability to process blood sugar (blood sugar). Prominent players in the diabetic food market have launched several new products for the diabetic food market to ensure better health for consumers. Food technologies can control obesity and diabetes by enabling the use of high-quality, low-cost, healthy, and nutritious foods.
The global diabetes therapies market reached nearly $50.7 billion in 2015 and grew at an annual rate of 4.5% in 2014. Emerging market growth due to an aging population has led to increasing demand for high-quality, inexpensive diabetic foods. Factors that have negatively affected growth over the historical period have been a lack of awareness and high investment costs.
Due to increasing life expectancy, changing lifestyles, and increasing incidence, the prevalence of diabetes in India has increased due to the changing lifestyle of the population and the increasing incidence of obesity.
The diabetes drug market is therefore expected to offer significant growth opportunities for the BRIC economies in the coming years. Besides, companies in India also offer easy-to-use insulin variants to gain a larger share of this market and the global insulin market. Together, these BRICS countries hold the largest market for diabetes drugs and insulin products in Asia-Pacific and Latin America, accounting for more than 60% of the global diabetes market share and over 80% in Africa.
The BRIC market for diabetes drugs will grow from $3.9 billion in 2009 to $8.7 billion in 2014, growing 17.1% between 2009 and 2014. In 2009, oral medicines accounted for about 65% of the market, but injectable medicines are expected to improve living standards, with the BRICS “incidence of diabetes rising to a staggering 150 million by 2030.
India has the highest prevalence of diabetes, with an estimated 69.2 million people living with diabetes in 2015. As the latest report from Market Research Future reveals, the Indian diabetes market has been thoroughly examined in its latest research report.
In India, the diabetes market is driven by increasing urbanization, the growing number of diabetics, and increased awareness of the disease and its causes, which has increased significantly, boosting demand for effective treatment of diabetes. Increasing urbanization and the resulting lifestyle changes have led to an increased number of diabetics, which promotes market growth. Increasing awareness of diabetes, increased public and private sector spending on diabetes treatment, the expansion of health infrastructure, and the increasing number of people with diabetes in India are driving this market for diabetics.
The Indian diabetes market is expected to grow by an average of 6.5% between 2016 and 2023. The Indian diabetes market is expected to grow from $4778.7 million in 2016 to $7441.6 million in 2016-17.
Diabetes has reached potential epidemic status in India, where it currently affects around 65 million people, according to the World Health Organization (WHO).
The Indian population, which has long been exposed to nutrition, is now exposed to it through a sedentary lifestyle, according to the WHO.
Together with the fact that Indians are genetically more susceptible to diabetes than other populations, India’s battle with diabetes is expected to be one of the largest epidemics the country has ever experienced. But their diabetes statistics are a goldmine, and alarm bells are ringing. As diabetics become increasingly health-conscious and North America and Europe follow in the footsteps of countries such as Australia, China, Japan, and South Korea, it is expected to be the dominant market.
For more such informative articles, click here!